Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 33 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2026 Filed Feb 27, 2026 21:49 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 12,378 | $23.86 | $295,339.08 |
DisclosureSEC source: 0000904454-26-000141 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 639,076 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.64 to $24.06. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:42 UTC |
KLEMT CHRISTIANChief Financial Officer
|
SaleOrdinary Shares | 6,217 | $23.86 | $148,337.62 |
DisclosureSEC source: 0000904454-26-000139 · edgar.xml · nonDerivative · entry 1 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,513 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.64 to $24.06. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:26 UTC |
Gut RobertDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,810 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0000904454-26-000021 · edgar.xml · derivative · entry 5 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,810 shares Expires 2032-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The Stock Option vested in full on June 15, 2023. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:26 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 7,803 | $25.09 | $195,777.27 |
DisclosureSEC source: 0000904454-26-000021 · edgar.xml · nonDerivative · entry 4 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,342 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:26 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 500 | $25.03 | $12,515.00 |
DisclosureSEC source: 0000904454-26-000021 · edgar.xml · nonDerivative · entry 3 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,145 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.02 to $25.04. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:26 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 17,310 | $24.39 | $422,190.90 |
DisclosureSEC source: 0000904454-26-000021 · edgar.xml · nonDerivative · entry 2 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,645 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.02 to $25.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:26 UTC |
Gut RobertDirector
|
Exercise / conversionOrdinary Shares | 17,810 | $14.08 | $250,764.80 |
DisclosureSEC source: 0000904454-26-000021 · edgar.xml · nonDerivative · entry 1 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 21:21 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,390 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-26-000013 · edgar.xml · derivative · entry 3 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,390 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on January 26, 2019. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 21:21 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 6,390 | $27.28 | $174,319.20 |
DisclosureSEC source: 0000904454-26-000013 · edgar.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,439 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.19 to $27.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 21:21 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 6,390 | $19.39 | $123,902.10 |
DisclosureSEC source: 0000904454-26-000013 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:54 UTC |
Gut RobertDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,840 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0000904454-25-000568 · edgar.xml · derivative · entry 4 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,840 shares Expires 2034-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The Stock Option vested in full on June 19, 2025. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:54 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 15,594 | $27.30 | $425,716.20 |
DisclosureSEC source: 0000904454-25-000568 · edgar.xml · nonDerivative · entry 3 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,145 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:54 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 15,840 | $27.22 | $431,164.80 |
DisclosureSEC source: 0000904454-25-000568 · edgar.xml · nonDerivative · entry 2 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,739 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.00 to $27.38. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:54 UTC |
Gut RobertDirector
|
Exercise / conversionOrdinary Shares | 15,840 | $4.57 | $72,388.80 |
DisclosureSEC source: 0000904454-25-000568 · edgar.xml · nonDerivative · entry 1 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · balance_after: Adjusted to reflect (i) the sale of 1,120 shares under the Reporting Person's 10b5-1 plan on June 23, 2020, which was inadvertently omitted from the Form 4 filed on June 24, 2020, and (ii) the correction to a typographical error in the number of shares sold by the Reporting Person on June 13, 2024 reported on the Form 4 filed on June 17, 2024. The Form 4 reported the sale of 3,504 shares but should have reported the sale of 3,524 shares. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,810 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · derivative · entry 9 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,810 shares Expires 2032-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · derivative.exercise_date: The Stock Option vested in full on June 15, 2023. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · derivative · entry 8 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,000 shares Expires 2027-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · derivative.exercise_date: The Stock Option vested in full on January 27, 2018. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · derivative · entry 7 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Option vested 25% on June 30, 2018 and 6.25% quarterly thereafter. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 17,810 | $30.33 | $540,177.30 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · nonDerivative · entry 6 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,439 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.90. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 17,810 | $14.08 | $250,764.80 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · nonDerivative · entry 5 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 11,000 | $30.34 | $333,740.00 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · nonDerivative · entry 4 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,439 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.16 to $30.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 11,000 | $5.37 | $59,070.00 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · nonDerivative · entry 3 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 10,000 | $30.36 | $303,600.00 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,439 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.20 to $30.79. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:01 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 10,000 | $7.37 | $73,700.00 |
DisclosureSEC source: 0000904454-25-000560 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 26, 2025 Filed Sep 26, 2025 23:37 UTC |
KLEMT CHRISTIANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0000904454-25-000455 · edgar.xml · derivative · entry 6 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2027-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 13, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Option vested 25% on January 27, 2018 and 6.25% quarterly thereafter, and is scheduled to expire on January 27, 2027. Read SEC document |
| September 26, 2025 Filed Sep 26, 2025 23:37 UTC |
KLEMT CHRISTIANChief Financial Officer
|
SaleOrdinary Shares | 15,000 | $55.00 | $825,000.00 |
DisclosureSEC source: 0000904454-25-000455 · edgar.xml · nonDerivative · entry 4 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,730 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 13, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in muliple transactions at prices ranging from $55.00 to $55.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 26, 2025 Filed Sep 26, 2025 23:37 UTC |
KLEMT CHRISTIANChief Financial Officer
|
Exercise / conversionOrdinary Shares | 15,000 | $5.37 | $80,550.00 |
DisclosureSEC source: 0000904454-25-000455 · edgar.xml · nonDerivative · entry 3 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 13, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $6.22 | $0.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · derivative · entry 9 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 175,000 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F9 · derivative.exercise_date: The Stock Option vested 25% on March 14, 2018 and 6.25% quarterly thereafter. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 51,316 | $0.00 Strike: $7.53 | $0.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · derivative · entry 8 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,316 shares Expires 2026-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · derivative.exercise_date: The Stock Option vested 25% on September 29, 2017 and 6.25% quarterly thereafter. F8 · balance_after: Adjusted to reflect the exercise and sale of 7,501 option shares under the Reporting Person's 10b5-1 plan on February 19, 2020. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 60,000 | $45.10 | $2,706,000.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 7 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 651,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 5,022 | $41.69 | $209,367.18 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 711,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.56 to $41.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 49,978 | $40.68 | $2,033,105.04 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 716,476 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.42 to $41.42 The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 60,000 | $40.04 | $2,402,400.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 766,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 51,316 | $39.59 | $2,031,600.44 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 826,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.20 to $40.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionOrdinary Shares | 175,000 | $6.22 | $1,088,500.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 877,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionOrdinary Shares | 51,316 | $7.53 | $386,409.48 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:37 UTC |
KLEMT CHRISTIANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $13.03 | $0.00 |
DisclosureSEC source: 0000904454-25-000455 · edgar.xml · derivative · entry 5 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,000 shares Expires 2026-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 13, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested 25% on April 15, 2016 and 6.25% quarterly thereafter, and is scheduled to expire on April 15, 2026. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:37 UTC |
KLEMT CHRISTIANChief Financial Officer
|
SaleOrdinary Shares | 3,000 | $40.04 | $120,120.00 |
DisclosureSEC source: 0000904454-25-000455 · edgar.xml · nonDerivative · entry 2 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,730 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 13, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:37 UTC |
KLEMT CHRISTIANChief Financial Officer
|
Exercise / conversionOrdinary Shares | 3,000 | $13.03 | $39,090.00 |
DisclosureSEC source: 0000904454-25-000455 · edgar.xml · nonDerivative · entry 1 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 13, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 20:49 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 1,466 | $13.92 | $20,406.72 |
DisclosureSEC source: 0000904454-25-000350 · edgar.xml · nonDerivative · entry 1 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,437 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.90 to $14.05. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 22:03 UTC |
POST LEONARD EDirector
|
SaleOrdinary Shares | 2,112 | $14.45 | $30,518.40 |
DisclosureSEC source: 0000904454-25-000338 · edgar.xml · nonDerivative · entry 1 POST LEONARD E · CIK 0001235862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,937 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:53 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 2,112 | $14.45 | $30,518.40 |
DisclosureSEC source: 0000904454-25-000336 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,439 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:34 UTC |
Meek David D.Director
|
SaleOrdinary Shares | 2,112 | $14.45 | $30,518.40 |
DisclosureSEC source: 0000904454-25-000328 · edgar.xml · nonDerivative · entry 1 Meek David D. · CIK 0001555337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,190 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:42 UTC |
Balachandran MadhavanDirector
|
SaleOrdinary Shares | 2,112 | $14.45 | $30,518.40 |
DisclosureSEC source: 0000904454-25-000330 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,697 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 22:08 UTC |
Springhorn Jeremy P.Director
|
SaleOrdinary Shares | 2,112 | $14.45 | $30,518.40 |
DisclosureSEC source: 0000904454-25-000340 · edgar.xml · nonDerivative · entry 1 Springhorn Jeremy P. · CIK 0001717852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,694 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:50 UTC |
Jacques Rachelle SuzanneDirector
|
SaleOrdinary Shares | 2,112 | $14.45 | $30,518.40 |
DisclosureSEC source: 0000904454-25-000334 · edgar.xml · nonDerivative · entry 1 Jacques Rachelle Suzanne · CIK 0001772610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,346 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:45 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 3,336 | $14.45 | $48,205.20 |
DisclosureSEC source: 0000904454-25-000332 · edgar.xml · nonDerivative · entry 1 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,879 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2025 Filed Jun 20, 2025 23:43 UTC |
Potts JeannetteChief Legal Officer
|
SaleOrdinary Shares | 4,670 | $15.14 | $70,703.80 |
DisclosureSEC source: 0000904454-25-000326 · edgar.xml · nonDerivative · entry 1 Potts Jeannette · CIK 0001814693 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,073 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:07 UTC |
POST LEONARD EDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,630 | $0.00 Strike: $16.22 | $0.00 |
DisclosureSEC source: 0000904454-25-000318 · edgar.xml · derivative · entry 2 POST LEONARD E · CIK 0001235862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,630 Underlying: Ordinary Shares · 15,630 shares Expires 2035-06-11 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:07 UTC |
POST LEONARD EDirector
|
GrantOrdinary Shares | 7,970 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-25-000318 · edgar.xml · nonDerivative · entry 1 POST LEONARD E · CIK 0001235862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,049 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:01 UTC |
Kaye JackDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,630 | $0.00 Strike: $16.22 | $0.00 |
DisclosureSEC source: 0000904454-25-000316 · edgar.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,630 Underlying: Ordinary Shares · 15,630 shares Expires 2035-06-11 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.